Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporin ophthalmic nanoemulsion vs cyclosporin emulsion vs diquafosol for dry eye disease
KCT0002180Phase 4Completed
- Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Start
- Oct 2016
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine, diquafosol in dry eye syndrome (DED), sponsored by Taejoon Pharmaceutical Co., Ltd.. Started Oct 2016; status: completed.
02
Drugs
cyclosporinediquafosol
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on KCT0002180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002180.